TTB.AU · Total Brain Limited

-

Please sign in to comment on TTB.AU

1 Comment

Admin

4 years, 1 month ago

Total Brain Limited is currently in a long term downtrend where the price is trading 2.4% below its 200 day moving average.

From a valuation standpoint, the stock is 95.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.6.

Total Brain Limited's total revenue sank by 9.1% to $2M since the same quarter in the previous year.

Its net income has dropped by 3.5% to $-4M since the same quarter in the previous year.

Finally, its free cash flow grew by 33.6% to $-2M since the same quarter in the previous year.

Based on the above factors, Total Brain Limited gets an overall score of 2/5.

Sector	Healthcare
Industry	Health Information Services
Exchange	AU
CurrencyCode	AUD
ISIN	AU0000032435

Target Price	0.24
Market Cap	267K
PE Ratio	None
Dividend Yield	0.0%
Beta	1.37

ABOUT

Total Brain Limited

Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia. The company offers Total Brain, a mental health monitoring and support platform, that helps users to measure their brain capacities while managing the risk of common mental conditions. It serves companies, providers, affinity groups, and precision medicine sectors. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018. Total Brain Limited was incorporated in 2000 and is based in Surry Hills, Australia.

TTB.AU · Total Brain Limited

-

Total Brain Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Total Brain Limited using a moving average strategy